16 Cervix Carcinoma

Cervix Cancer 359

28. Eifel PJ, Morris M, Wharton JT, Oswald MJ. The influence of tumor size and morphology on the outcome of patients with FIGO stage IB squamous cell carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1994; 29 : 9-16. 29. Eifel PJ, Levenback C, Wharton JT, Oswald MJ. Time course and incidence of late complications in patients treated with radiation therapy for FIGO stage IB carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys 1995; 32 : 1289-300. 30. Esche BA, Crook JM, Horiot JC. Dosimetric methods in the optimization of radiotherapy for carcinoma of the uterine cervix. Int J Radiat Oncol Biol Phys. 1987; 13 : 1183-92. 31. Fellner C, Pötter R, Knocke TH, et al. CT-based treatment planning in cervix carcinoma – dose reduction to the rectum and its impact on the dose to the CTV: a retrospective analysis . Radiother Oncol 2001; 60 (suppl 1) : 2. 32. Fellner C, Pötter R, Knocke TH, Wambersie A. Comparison of radiography- and computed tomography-based treatment planning in cervix cancer brachytherapy with specific attention to some quality assurance aspects. Radioth Oncol 2001; 58: 53-62 33. FIGO classification 5 th edition 1997. 34. FIGO annual report on the results of treatment in gynaecological cancer. 23 rd volume, J Epidemiol Bios 1998; 3 : 20-6. 35. Fletcher GH, Hamburger AD. Female Pelvis. Squamous cell carcinoma of the Uterine Cervix. In GH Fletcher (ed.): Textbook of radiotherapy . Philadelphia: Lea and Febiger, 3 rd edition 1980; 720-89. 36. Fletcher GH Cancer of the uterine cervix: Janeway lecture. Am J Roentgenol Radium Ther Nucl Med 1971; 111 : 225-42. 37. Gerbaulet A, Maher M, Haie-Meder C, et al. Cancer of the cervix (K. Morita). The Paris Method. In: Vahrson HV (ed.). Rad Oncol Gynecol Cancer . New York: Springer, 1997: 198- 205. 38. Gerbaulet A, Bridier A, Haie-Meder C, et al. Curiethérapie des cancers du col utérin. Méthode de lnstitut Gustave-Roussy. Bull Cancer Radiother 1992; 79 : 107-17. 39. Gerbaulet A, Kunkler I, Kerr GR, et al. Combined radiotherapy and surgery: Local control and complications in early carcinoma of the uterine cervix. The Villejuif experience, 1975-84. Radioth Oncol 1992; 23 : 66-73. 40. Gerbaulet A, Lartigau E, Haie-Meder C, et al. Le Cancer du col uterin de la femme jeune . Contracep Fertil Sex 1994; 22 : 1-11. 41. Gerbaulet A, Haie C, Michel G, et al. Combined radio-surgical treatment in early invasive cervix carcinoma according to prognostic factors. Experience of the Gustave-Roussy Institute. Eur J Gynecol Oncol 1992; 13 : 256-61. 42. Gerbaulet A, Michel G, Haie-Meder C, et al. The role of low dose rate brachytherapy in the treatment of cervix carcinoma. Experience of the Gustave-Roussy Institute on 1245 patients. Eur J Gynecol Oncol 1995; 16 : 461-75. 43. Gerbaulet A, Lartigau E, Haie-Meder C, et al. How can laparoscopic management assist radiation treatment in cervix carcinoma? Radiother Oncol 1999; 51 : 9-13. 44. Gerstner N, Wachter S, Reinstadler E, et al. Radiography compared to sectional image (CT/MR) based 3D treatment planning in cervix cancer brachytherapy: results of a prospective comparative trial. Radiother Oncol 2001; 60 (suppl 1) : 3. 45. Girinski T, Rey A, Roche B, et al. Overall treatment time in advanced cervical carcinomas: a critical parameter in treatment outcme. Int J Radiat Oncol Biol Phys 1993; 27(5) : 1051-6. 46. Green JA, Kirwan JM, Tierney JF, et al. Survival and recurrence after concomitant chemotherapy and radiotherapy for cancer of the uterine cervix: a systematic review and meta-analysis. Lancet 2001; 358 : 781-6. 47. Grigsby PW, Perez CA, Kuske RR, et al. Adenocarcinoma of the uterine cervix: lack of evidence for a poorer prognosis. Radiother Oncol 1988; 12 : 289-96. 48. Gupta BD, Ayyagari S, Sharma SC, et al. Optimal time-dose-fractionation of HDR brachytherapy and comparison with conventional dose-rate brachytherapy. In: Mould RF ed. Brachytherapy. Leersum, Netherlends, Nucletron International 1989; 2 : 307-8.